Pharmacoeconomic Study of the Eliquis (Apixaban) Use Within the Program of Essential Medicines Provision in the Russian Federation
Medical Technologies. Assessment and Choice
doi 10.31556/2219-0678.2018.32.2.094-102
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Fund Gelios